NCT00338078

Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration

Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration. A Randomized Double-Blind Placebo Controlled Cross-Over Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 62 (actual)
• Sponsor: Umeå University · Academic / Other
• Sex: All
• Age: 19 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether oxygen therapy during sleep improves quality of life, exercise capacity and heart function among patients with chronic heart failure and central sleep apnea.

Detailed description

Oxygen therapy reduces the number of central apneas among patients with congestive heart failure but it is unknown whether quality of life and heart function also improve. We aim to test whether the quality of life, exercise capacity and heart function are improved with nocturnal oxygen therapy during 6 weeks with nocturnal oxygen from oxygen concentrator or nocturnal air from placebo concentrator.

Conditions

• Heart Failure

Interventions

Type	Name	Description
DEVICE	nocturnal oxygen treatment from oxygen concentrators

Timeline

• Start date: 1999-03-01
• Completion: 2006-12-01
• First posted: 2006-06-20
• Last updated: 2008-07-02

Locations

1 site across 1 country: Sweden